All Stories

  1. Clinically important improvements in 6-minute walk distance and forced vital capacity in adults with late-onset Pompe disease switching from alglucosidase alfa to cipaglucosidase alfa plus miglustat in the PROPEL study

    Article • Neuromuscular Disorders, March 2026, Elsevier

    Dr Stephan Wenninger

  2. Nociceptive Pain in Patients with Neuromuscular Disorders: A Cross-Sectional Clinical Study

    Article • Journal of Neuromuscular Diseases, September 2024, IOS Press

    Dr Stephan Wenninger

  3. Expanding the Clinical Spectrum of IgLON5-Syndrome

    Article • Journal of Neuromuscular Diseases, November 2017, IOS Press

    Dr Stephan Wenninger

  4. Das Spektrum der Neuromyotonie: Klinik, Therapie und Langzeitverlauf

    Article • Fortschritte der Neurologie · Psychiatrie, September 2015, Thieme Publishing Group

    Dr Stephan Wenninger